Welcome to the July 2026 edition of our Asset Management & Investment Funds update – ‘Funds Focus’.
In this month’s edition we look at:
- Key Dates & Deadlines: Q2 2026
Stay ahead of upcoming deadlines and key dates with our legal & regulatory tracker along with possible dates and impacts for fund managers. - New CBI UCITS Regulations
On 7 July 2026, CBI UCITS Regulations 2026 were published with immediate effect, repealing and replacing the 2019 Regulations. - ESMA Risk Management function CSA
ESMA is launching a Common Supervisory Action on the risk management function of UCITS management companies and Alternative Investment Fund Managers across the European Union. - CBI Delegation review
The CBI provided a high-level overview of the findings from its 2025 delegation review of Fund Management Companies to Irish Funds. The full industry report is expected in July. - EU Retail Investment Strategy update
The EU Retail Investment Strategy package was endorsed by the European Council in June 2026. Updates include value-for-money proposals for retail UCITS and AIFs and PRIIPs KID changes. - EU Markets Integration and Supervision Package update
Draft amendments in June 2026 to the European Commission’s MISP proposal by representatives of the European Parliament’s Economic and Monetary Affairs Committee. - CBI Authorisations and Gatekeeping report
The CBI published the third edition of its Authorisations and Gatekeeping Report providing a comprehensive overview of authorisation and gatekeeping activity across all regulated sectors in 2025. - ESMA MiFID conflicts of interest in distribution CSA
ESMA will launch a common supervisory action in 2026 with national competent authorities on conflicts of interest in the distribution of financial instruments. - Money Market Fund consultation
The CBI recently published a consultation paper on Guidance on Money Market Fund Weekly Liquid Assets levels (CP168). - UCITS Regulations: update to derivatives classification
Amended UCITS Regulations classifying derivatives as centrally or non-centrally cleared with a CCP authorised or recognised under EMIR instead of either exchange-traded or over-the-counter.
Click the pdf below to download our full briefing.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
